Skip to main content
Top
Published in: BMC Infectious Diseases 1/2012

Open Access 01-12-2012 | Research article

Macrolide-resistant Mycoplasma pneumoniae in adolescents with community-acquired pneumonia

Authors: Naoyuki Miyashita, Yasuhiro Kawai, Hiroto Akaike, Kazunobu Ouchi, Toshikiyo Hayashi, Takeyuki Kurihara, Niro Okimoto, the Atypical Pathogen Study Group

Published in: BMC Infectious Diseases | Issue 1/2012

Login to get access

Abstract

Background

Although the prevalence of macrolide-resistant Mycoplasma pneumoniae isolates in Japanese pediatric patients has increased rapidly, there have been no reports concerning macrolide-resistant M. pneumoniae infection in adolescents aged 16 to 19 years old. The purpose of this study was to clarify the prevalence and clinical characteristics of macrolide-resistant M. pneumoniae in adolescent patients with community-acquired pneumonia.

Methods

A total of 99 cases with M. pneumoniae pneumonia confirmed by polymerase chain reaction (PCR) and culture were analyzed. Forty-five cases were pediatric patients less than 16 years old, 26 cases were 16 to 19-year-old adolescent patients and 28 cases were adult patients. Primers for domain V of 23S rRNA were used and DNA sequences of the PCR products were compared with the sequence of an M. pneumoniae reference strain.

Results

Thirty of 45 pediatric patients (66%), 12 of 26 adolescent patients (46%) and seven of 28 adult patients (25%) with M. pneumoniae pneumonia were found to be infected with macrolide-resistant M. pneumoniae (MR patients). Although the prevalence of resistant strains was similar in pediatric patients between 2008 and 2011, an increase in the prevalence of resistant strains was observed in adolescent patients. Among 30 pediatric MR patients, 26 had an A-to-G transition at position 2063 (A2063G) and four had an A-to-G transition at position 2064 (A2064G). In 12 adolescent MR patients, 10 showed an A2063G transition and two showed an A2064G transition, and in seven adult MR patients, six showed an A2063G transition and one showed an A2064G transition.

Conclusions

The prevalence of macrolide-resistant M. pneumoniae is high among adolescent patients as well as pediatric patients less than 16-years old. To prevent outbreaks of M. pneumoniae infection, especially macrolide-resistant M. pneumoniae, in closed populations including among families, in schools and in university students, physicians should pay close attention to macrolide-resistant M. pneumoniae.
Appendix
Available only for authorised users
Literature
1.
go back to reference The committee for the Japanese Respiratory Society guidelines in management of respiratory infections: The Japanese Respiratory Society guideline for the management of community-acquired pneumonia in adults. Respirology. 2006, 11 (Suppl 3): 79-133. The committee for the Japanese Respiratory Society guidelines in management of respiratory infections: The Japanese Respiratory Society guideline for the management of community-acquired pneumonia in adults. Respirology. 2006, 11 (Suppl 3): 79-133.
3.
go back to reference Rasmussen JN, Voldstedlund M, Andersen RL, Ellermann-Eriksen S, Jensen TG, Johansen HK, Kolmos B, Molvadgaard M, Nielsen SS, Olsen E, Schonning K, Uldum SA: Increased incidence ofMycoplasma pneumoniaeinfections detected by laboratory-based surveillance in Denmark in 2010. Euro Surveill. 2010, 15: 45- Rasmussen JN, Voldstedlund M, Andersen RL, Ellermann-Eriksen S, Jensen TG, Johansen HK, Kolmos B, Molvadgaard M, Nielsen SS, Olsen E, Schonning K, Uldum SA: Increased incidence ofMycoplasma pneumoniaeinfections detected by laboratory-based surveillance in Denmark in 2010. Euro Surveill. 2010, 15: 45-
4.
go back to reference Chalker V, Stocki T, Mentasti M, Fleming D, Harrison T: Increased incidence ofMycoplasma pneumoniaeinfection in England and Wales in 2010: multiocus variable number tandem repeat analysis typing and macrolide susceptibility. Euro Surveill. 2011, 16: 19- Chalker V, Stocki T, Mentasti M, Fleming D, Harrison T: Increased incidence ofMycoplasma pneumoniaeinfection in England and Wales in 2010: multiocus variable number tandem repeat analysis typing and macrolide susceptibility. Euro Surveill. 2011, 16: 19-
5.
go back to reference Averbuch D, Hidalgo-Grass C, Moses AE, Engelhard D, Nir-Paz R: Macrolide resistance inMycoplasma pneumoniae,Israel, 2010. Emerg Infect Dis. 2011, 17 (6): 1079-1082. 10.3201/eid1706.101558.CrossRefPubMedPubMedCentral Averbuch D, Hidalgo-Grass C, Moses AE, Engelhard D, Nir-Paz R: Macrolide resistance inMycoplasma pneumoniae,Israel, 2010. Emerg Infect Dis. 2011, 17 (6): 1079-1082. 10.3201/eid1706.101558.CrossRefPubMedPubMedCentral
6.
go back to reference Polkowska A, Harjunpää A, Toikkanen S, Lappalainen M, Vuento R, Vuorinen T, Kauppinen J, Flinck H, Lyytikäinen O: Increased incidence of Mycoplasma pneumoniae infection in Finland, 2010–2011. Euro Surveill. 2012, 17 (5): Polkowska A, Harjunpää A, Toikkanen S, Lappalainen M, Vuento R, Vuorinen T, Kauppinen J, Flinck H, Lyytikäinen O: Increased incidence of Mycoplasma pneumoniae infection in Finland, 2010–2011. Euro Surveill. 2012, 17 (5):
7.
go back to reference Blystad H, Ånestad G, Vestrheim DF, Madsen S, Rønning K: Increased incidence of Mycoplasma pneumoniae infection in Norway 2011. Euro Surveill. 2012, 17 (5): Blystad H, Ånestad G, Vestrheim DF, Madsen S, Rønning K: Increased incidence of Mycoplasma pneumoniae infection in Norway 2011. Euro Surveill. 2012, 17 (5):
8.
go back to reference Uldum SA, Bangsborg JM, Gahrn-Hansen B, Ljung R, Mølvadgaard M, Føns Petersen R, Wiid Svarrer C: Epidemic of Mycoplasma pneumoniae infection in Denmark, 2010 and 2011. Euro Surveill. 2012, 17 (5): Uldum SA, Bangsborg JM, Gahrn-Hansen B, Ljung R, Mølvadgaard M, Føns Petersen R, Wiid Svarrer C: Epidemic of Mycoplasma pneumoniae infection in Denmark, 2010 and 2011. Euro Surveill. 2012, 17 (5):
9.
go back to reference Chalker VJ, Stocki T, Litt D, Bermingham A, Watson J, Fleming DM, Harrison TG: Increased detection ofMycoplasma pneumoniaeinfection in children in England and Wales, October 2011 to January 2012. Euro Surveill. 2012, 17: 6- Chalker VJ, Stocki T, Litt D, Bermingham A, Watson J, Fleming DM, Harrison TG: Increased detection ofMycoplasma pneumoniaeinfection in children in England and Wales, October 2011 to January 2012. Euro Surveill. 2012, 17: 6-
10.
go back to reference Linde A, Ternhag A, Törner A, Claesson BE: Antibiotic prescriptions and laboratory-confirmed cases ofMycoplasma pneumoniaeduring the epidemic in Sweden in 2011. Euro Surveill. 2012, 17: 6- Linde A, Ternhag A, Törner A, Claesson BE: Antibiotic prescriptions and laboratory-confirmed cases ofMycoplasma pneumoniaeduring the epidemic in Sweden in 2011. Euro Surveill. 2012, 17: 6-
11.
go back to reference Eibach D, Escuret V, Billaud G, Mekki Y, Frobert E, Bouscambert-Duchamp M, Lina B, Morfin F: Increased detection ofMycoplasma pneumoniaeinfection in children, Lyon, France, 2010 to 2011. Euro Surveill. 2012, 17: 8- Eibach D, Escuret V, Billaud G, Mekki Y, Frobert E, Bouscambert-Duchamp M, Lina B, Morfin F: Increased detection ofMycoplasma pneumoniaeinfection in children, Lyon, France, 2010 to 2011. Euro Surveill. 2012, 17: 8-
12.
go back to reference Matsuoka M, Narita M, Okazaki N, Ohya H, Yamazaki T, Ouchi K, Suzuki I, Andoh T, Kenri T, Sasaki Y, Horino A, Shintani M, Arakawa Y, Sasaki T: Characterization and molecular analysis of macrolide-resistantMycoplasma pneumoniaeclinical isolates obtained in Japan. Antimicrob Agents Chemother. 2004, 48 (12): 4624-4630. 10.1128/AAC.48.12.4624-4630.2004.CrossRefPubMedPubMedCentral Matsuoka M, Narita M, Okazaki N, Ohya H, Yamazaki T, Ouchi K, Suzuki I, Andoh T, Kenri T, Sasaki Y, Horino A, Shintani M, Arakawa Y, Sasaki T: Characterization and molecular analysis of macrolide-resistantMycoplasma pneumoniaeclinical isolates obtained in Japan. Antimicrob Agents Chemother. 2004, 48 (12): 4624-4630. 10.1128/AAC.48.12.4624-4630.2004.CrossRefPubMedPubMedCentral
13.
go back to reference Okazaki N, Narita M, Yamada S, Izumikawa K, Umetsu M, Kenri T, Sasaki Y, Arakawa Y, Sasaki T: Characteristics of macrolide-resistantMycoplasma pneumoniaestrains isolated from patients and induced with erythromycin in vitro. Microbiol Immunol. 2001, 45 (8): 617-620.CrossRefPubMed Okazaki N, Narita M, Yamada S, Izumikawa K, Umetsu M, Kenri T, Sasaki Y, Arakawa Y, Sasaki T: Characteristics of macrolide-resistantMycoplasma pneumoniaestrains isolated from patients and induced with erythromycin in vitro. Microbiol Immunol. 2001, 45 (8): 617-620.CrossRefPubMed
14.
go back to reference Morozumi M, Takahashi T, Ubukata K: Macrolide-resistantMycoplasma pneumoniae: characteristics of isolates and clinical aspects of community-acquired pneumonia. J Infect Chemother. 2010, 16 (2): 78-86. 10.1007/s10156-009-0021-4.CrossRefPubMed Morozumi M, Takahashi T, Ubukata K: Macrolide-resistantMycoplasma pneumoniae: characteristics of isolates and clinical aspects of community-acquired pneumonia. J Infect Chemother. 2010, 16 (2): 78-86. 10.1007/s10156-009-0021-4.CrossRefPubMed
15.
go back to reference Miyashita N, Kawai Y, Yamaguchi T, Ouchi K, Oka M, Atypical Pathogen Study Group: Macrolide-resistant Mycoplasma pneumoniae in adults with community-acquired pneumonia. Int J Antimicrob Agents. 2010, 36 (4): 384-385. 10.1016/j.ijantimicag.2010.06.009.CrossRefPubMed Miyashita N, Kawai Y, Yamaguchi T, Ouchi K, Oka M, Atypical Pathogen Study Group: Macrolide-resistant Mycoplasma pneumoniae in adults with community-acquired pneumonia. Int J Antimicrob Agents. 2010, 36 (4): 384-385. 10.1016/j.ijantimicag.2010.06.009.CrossRefPubMed
16.
go back to reference Suzuki S, Yamazaki T, Narita M, Okazaki N, Suzuki I, Andoh T, Matsuoka M, Kenri T, Arakawa Y, Sasaki T: Clinical evaluation of macrolide-resistantMycoplasma pneumoniae. Antimicrob Agents Chemother. 2006, 50 (2): 709-712. 10.1128/AAC.50.2.709-712.2006.CrossRefPubMedPubMedCentral Suzuki S, Yamazaki T, Narita M, Okazaki N, Suzuki I, Andoh T, Matsuoka M, Kenri T, Arakawa Y, Sasaki T: Clinical evaluation of macrolide-resistantMycoplasma pneumoniae. Antimicrob Agents Chemother. 2006, 50 (2): 709-712. 10.1128/AAC.50.2.709-712.2006.CrossRefPubMedPubMedCentral
17.
go back to reference Matsubara K, Morozumi M, Okada T, Matsushima T, Komiyama O, Shoji M, Ebihara T, Ubukata K, Sato Y, Akita H, Sunakawa K, Iwata S: A comparative clinical study of macrolide-sensitive and macrolide-resistantMycoplasma pneumoniaeinfections in pediatric patients. J Infect Chemother. 2009, 15 (6): 380-383. 10.1007/s10156-009-0715-7.CrossRefPubMed Matsubara K, Morozumi M, Okada T, Matsushima T, Komiyama O, Shoji M, Ebihara T, Ubukata K, Sato Y, Akita H, Sunakawa K, Iwata S: A comparative clinical study of macrolide-sensitive and macrolide-resistantMycoplasma pneumoniaeinfections in pediatric patients. J Infect Chemother. 2009, 15 (6): 380-383. 10.1007/s10156-009-0715-7.CrossRefPubMed
18.
go back to reference Kawai Y, Miyashita N, Yamaguchi T, Saitoh A, Kondoh E, Fujimoto H, Teranishi H, Inoue M, Wakabayashi T, Akaike H, Ogita S, Kawasaki K, Terada K, Kishi F, Ouchi K: Clinical efficacy of macrolide antibiotics against genetically determined macrolide-resistantMycoplasma pneumoniaepneumonia in pediatric patients. Respirology. 2012, 17 (2): 354-362. 10.1111/j.1440-1843.2011.02102.x.CrossRefPubMed Kawai Y, Miyashita N, Yamaguchi T, Saitoh A, Kondoh E, Fujimoto H, Teranishi H, Inoue M, Wakabayashi T, Akaike H, Ogita S, Kawasaki K, Terada K, Kishi F, Ouchi K: Clinical efficacy of macrolide antibiotics against genetically determined macrolide-resistantMycoplasma pneumoniaepneumonia in pediatric patients. Respirology. 2012, 17 (2): 354-362. 10.1111/j.1440-1843.2011.02102.x.CrossRefPubMed
19.
go back to reference Miyashita N, Kawai Y, Yamaguchi T, Ouchi K, Oka M, Atypical Pathogen Study Group: Clinical potential of diagnostic methods for the rapid diagnosis of Mycoplasma pneumoniae pneumonia in adults. Eur J Clin Microbiol Infect Dis. 2011, 30 (3): 439-446. 10.1007/s10096-010-1107-8.CrossRefPubMed Miyashita N, Kawai Y, Yamaguchi T, Ouchi K, Oka M, Atypical Pathogen Study Group: Clinical potential of diagnostic methods for the rapid diagnosis of Mycoplasma pneumoniae pneumonia in adults. Eur J Clin Microbiol Infect Dis. 2011, 30 (3): 439-446. 10.1007/s10096-010-1107-8.CrossRefPubMed
20.
go back to reference Lucier TS, Heitzman K, Liu SK, Hu PC: Transition mutations in the 23 S rRNA of erythromycin-resistant isolates ofMycoplasma pneumoniae. Antimicrob Agents Chemother. 1995, 39 (12): 2770-2773. 10.1128/AAC.39.12.2770.CrossRefPubMedPubMedCentral Lucier TS, Heitzman K, Liu SK, Hu PC: Transition mutations in the 23 S rRNA of erythromycin-resistant isolates ofMycoplasma pneumoniae. Antimicrob Agents Chemother. 1995, 39 (12): 2770-2773. 10.1128/AAC.39.12.2770.CrossRefPubMedPubMedCentral
21.
go back to reference Isozumi R, Yoshimine H, Morozumi M, Ubukata K, Ariyoshi K: Adult community-acquired pneumonia caused by macrolide resistantMycoplasma pneumoniae. Respirology. 2009, 14 (8): 1206-1208. 10.1111/j.1440-1843.2009.01619.x.CrossRefPubMed Isozumi R, Yoshimine H, Morozumi M, Ubukata K, Ariyoshi K: Adult community-acquired pneumonia caused by macrolide resistantMycoplasma pneumoniae. Respirology. 2009, 14 (8): 1206-1208. 10.1111/j.1440-1843.2009.01619.x.CrossRefPubMed
22.
go back to reference Peuchant O, Menard A, Renaudin H, Morozumi M, Ubukata K, Bebear CM, Pereyre S: Increased macrolide resistance ofMycoplasma pneumoniae in France directly detected in clinical specimens by real-time PCR and melting curve analysis. J Antimicrob Chemother. 2009, 64 (1): 52-58. 10.1093/jac/dkp160.CrossRefPubMed Peuchant O, Menard A, Renaudin H, Morozumi M, Ubukata K, Bebear CM, Pereyre S: Increased macrolide resistance ofMycoplasma pneumoniae in France directly detected in clinical specimens by real-time PCR and melting curve analysis. J Antimicrob Chemother. 2009, 64 (1): 52-58. 10.1093/jac/dkp160.CrossRefPubMed
23.
go back to reference Wolff BJ, Thacker WL, Schwartz SB, Winchell JM: Detection of macrolide resistance inMycoplasma pneumoniaeby real-time PCR and high-resolution melt analysis. Antimicrob Agents Chemother. 2008, 52 (10): 3542-3549. 10.1128/AAC.00582-08.CrossRefPubMedPubMedCentral Wolff BJ, Thacker WL, Schwartz SB, Winchell JM: Detection of macrolide resistance inMycoplasma pneumoniaeby real-time PCR and high-resolution melt analysis. Antimicrob Agents Chemother. 2008, 52 (10): 3542-3549. 10.1128/AAC.00582-08.CrossRefPubMedPubMedCentral
24.
go back to reference Dumke R, von Baum H, Luck PC, Jacobs E: Occurrence of macrolide-resistantMycoplasma pneumoniaestrain in Germany. Clin Microbial Infect. 2010, 16 (6): 613-616. 10.1111/j.1469-0691.2009.02968.x.CrossRef Dumke R, von Baum H, Luck PC, Jacobs E: Occurrence of macrolide-resistantMycoplasma pneumoniaestrain in Germany. Clin Microbial Infect. 2010, 16 (6): 613-616. 10.1111/j.1469-0691.2009.02968.x.CrossRef
25.
go back to reference Chironna M, Sallustio A, Esposito S, Perulli M, Chinellato I, Di Bari C, Quarto M, Cardinale F: Emergence of macrolide-resistant strains during an outbreak ofMycoplasma pneumoniaeinfections in children. J Antimicrob Chemother. 2011, 66 (4): 734-737. 10.1093/jac/dkr003.CrossRefPubMed Chironna M, Sallustio A, Esposito S, Perulli M, Chinellato I, Di Bari C, Quarto M, Cardinale F: Emergence of macrolide-resistant strains during an outbreak ofMycoplasma pneumoniaeinfections in children. J Antimicrob Chemother. 2011, 66 (4): 734-737. 10.1093/jac/dkr003.CrossRefPubMed
26.
go back to reference Cao B, Zhao CJ, Yin YD, Zhao F, Song SF, Bai L, Zhang JZ, Liu YM, Zhang YY, Wang H, Wang C: High prevalence of macrolide resistance inMycoplasma pneumoniaeisolates from adult and adolescent patients with respiratory tract infection in China. Clin Infect Dis. 2010, 51 (2): 189-194. 10.1086/653535.CrossRefPubMed Cao B, Zhao CJ, Yin YD, Zhao F, Song SF, Bai L, Zhang JZ, Liu YM, Zhang YY, Wang H, Wang C: High prevalence of macrolide resistance inMycoplasma pneumoniaeisolates from adult and adolescent patients with respiratory tract infection in China. Clin Infect Dis. 2010, 51 (2): 189-194. 10.1086/653535.CrossRefPubMed
Metadata
Title
Macrolide-resistant Mycoplasma pneumoniae in adolescents with community-acquired pneumonia
Authors
Naoyuki Miyashita
Yasuhiro Kawai
Hiroto Akaike
Kazunobu Ouchi
Toshikiyo Hayashi
Takeyuki Kurihara
Niro Okimoto
the Atypical Pathogen Study Group
Publication date
01-12-2012
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2012
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/1471-2334-12-126

Other articles of this Issue 1/2012

BMC Infectious Diseases 1/2012 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.